A study on retinal angiomatous proliferation and its mechanism in apolipoprotein E-deficient mouse with dyslipidemia

Yi, WANG; Juan, WU; Luo-xiang, LI; Juan, LI; Qing-hua, ZENG; Xiao-hu, LIU.
Chinese Journal of Experimental Ophthalmology ; (12): 813-818, 2013.
Artículo en Zh | WPRIM | ID: wpr-636304

Documentos relacionados

  1. (<i>E</i>)-<i>N</i>-(3-(1-(2-(4-(2,2,2-Trifluoroacetamido)benzoyl)hydrazono)ethyl)phenyl)nicotinamide: A Novel Pyridine Derivative for Inhibiting Vascular Endothelial Growth Factor Receptor-2: Synthesis, Computational, and Anticancer Studies.
  2. Mechanotransduction via endothelial adhesion molecule CD31 initiates transmigration and reveals a role for VEGFR2 in diapedesis.
  3. Expression of VEGFR-2 and Meis1 in the early stage of kidney cancers and its clinical significance.
  4. Altered expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-1, vascular endothelial growth factor receptor-2, and Soluble Fms-like Tyrosine Kinase-1 in peripheral blood mononuclear cells from normal and preeclamptic pregnancies.
  5. Mechanism of the HIF-1&#945;/VEGF/VEGFR-2 pathway in the proliferation and apoptosis of human haemangioma endothelial cells.
  6. Neurons limit angiogenesis by titrating VEGF in retina.
  7. VEGFR2 insufficiency enhances phosphotoxicity and undermines Klotho's protection against peritubular capillary rarefaction and kidney fibrosis.